Physician profile
Christopher P Deans
NPI 1992138671
$417.88
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.64 · 2022: $29.15 · 2023: $41.30 · 2024: $129 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $148.84 | 2024-2025 | Xiaflex |
| Bioventus LLC | $92.52 | 2022-2024 | Durolane, Durolane |
| Moximed, INC | $30.65 | 2025 | Misha Knee System, Small, Left |
| Biodelivery Sciences International, INC. | $25.29 | 2021 | |
| Vertos Medical, INC. | $21.35 | 2021 | |
| Endo Pharmaceuticals INC. | $20.92 | 2023 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $20.73 | 2025 | |
| Pfizer INC. | $20.36 | 2025 | |
| Amgen INC. | $16.31 | 2024 | Prolia, Evenity |
| Depuy Synthes Sales INC. | $13.90 | 2025 | Monovisc, Orthovisc |
| Medela LLC | $7.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Deans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.